Masimo Earnings Calls
| Release date | Nov 04, 2025 |
| EPS estimate | $1.19 |
| EPS actual | $1.32 |
| EPS Surprise | 10.92% |
| Revenue estimate | 407.648M |
| Revenue actual | 371.5M |
| Revenue Surprise | -8.87% |
| Release date | Aug 05, 2025 |
| EPS estimate | $1.23 |
| EPS actual | $1.33 |
| EPS Surprise | 8.13% |
| Revenue estimate | 368.958M |
| Revenue actual | 370.9M |
| Revenue Surprise | 0.526% |
| Release date | May 06, 2025 |
| EPS estimate | $1.24 |
| EPS actual | $1.36 |
| EPS Surprise | 9.68% |
| Revenue estimate | 367.791M |
| Revenue actual | 372M |
| Revenue Surprise | 1.14% |
| Release date | Feb 25, 2025 |
| EPS estimate | $1.42 |
| EPS actual | $1.80 |
| EPS Surprise | 26.76% |
| Revenue estimate | 593.348M |
| Revenue actual | 600.7M |
| Revenue Surprise | 1.24% |
Last 4 Quarters for Masimo
Below you can see how MASI performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 25, 2025 |
| Price on release | $169.54 |
| EPS estimate | $1.42 |
| EPS actual | $1.80 |
| EPS surprise | 26.76% |
| Date | Price |
|---|---|
| Feb 19, 2025 | $179.43 |
| Feb 20, 2025 | $177.21 |
| Feb 21, 2025 | $169.96 |
| Feb 24, 2025 | $170.72 |
| Feb 25, 2025 | $169.54 |
| Feb 26, 2025 | $190.47 |
| Feb 27, 2025 | $186.20 |
| Feb 28, 2025 | $188.77 |
| Mar 03, 2025 | $190.63 |
| 4 days before | -5.51% |
| 4 days after | 12.44% |
| On release day | 12.35% |
| Change in period | 6.24% |
| Release date | May 06, 2025 |
| Price on release | $161.47 |
| EPS estimate | $1.24 |
| EPS actual | $1.36 |
| EPS surprise | 9.68% |
| Date | Price |
|---|---|
| Apr 30, 2025 | $160.96 |
| May 01, 2025 | $163.65 |
| May 02, 2025 | $166.42 |
| May 05, 2025 | $162.86 |
| May 06, 2025 | $161.47 |
| May 07, 2025 | $150.11 |
| May 08, 2025 | $153.58 |
| May 09, 2025 | $156.57 |
| May 12, 2025 | $163.56 |
| 4 days before | 0.317% |
| 4 days after | 1.29% |
| On release day | -7.04% |
| Change in period | 1.62% |
| Release date | Aug 05, 2025 |
| Price on release | $163.88 |
| EPS estimate | $1.23 |
| EPS actual | $1.33 |
| EPS surprise | 8.13% |
| Date | Price |
|---|---|
| Jul 30, 2025 | $156.02 |
| Jul 31, 2025 | $153.79 |
| Aug 01, 2025 | $153.95 |
| Aug 04, 2025 | $161.27 |
| Aug 05, 2025 | $163.88 |
| Aug 06, 2025 | $144.65 |
| Aug 07, 2025 | $144.90 |
| Aug 08, 2025 | $144.73 |
| Aug 11, 2025 | $147.37 |
| 4 days before | 5.04% |
| 4 days after | -10.07% |
| On release day | -11.73% |
| Change in period | -5.54% |
| Release date | Nov 04, 2025 |
| Price on release | $149.01 |
| EPS estimate | $1.19 |
| EPS actual | $1.32 |
| EPS surprise | 10.92% |
| Date | Price |
|---|---|
| Oct 29, 2025 | $142.91 |
| Oct 30, 2025 | $141.54 |
| Oct 31, 2025 | $140.65 |
| Nov 03, 2025 | $144.96 |
| Nov 04, 2025 | $149.01 |
| Nov 05, 2025 | $142.14 |
| Nov 06, 2025 | $143.84 |
| Nov 07, 2025 | $143.16 |
| Nov 10, 2025 | $144.50 |
| 4 days before | 4.27% |
| 4 days after | -3.03% |
| On release day | -4.61% |
| Change in period | 1.11% |
Masimo Earnings Call Transcript Summary of Q3 2025
Masimo delivered a strong Q3 2025: revenue grew 8% year-over-year, adjusted EPS increased 38%, operating margin expanded 450 basis points, and operating cash flow was $57 million. Key drivers included solid demand for technology boards/monitors (66,000 units shipped, +8% YoY), robust contract activity (incremental contract value of $124 million, +48% YoY) and improving commercial execution. Management closed the Sound United divestiture to Harman and used proceeds to pay down debt and repurchase shares—returning a total of $350 million to shareholders across Q3 and Q4. Masimo tightened fiscal 2025 revenue guidance to $1.510B–$1.530B, raised operating margin guidance to 27.3%–27.7%, and lifted adjusted EPS guidance to $5.40–$5.55 (up $0.15 at the midpoint). Company highlighted strategic priorities: (1) elevating commercial excellence to broaden cross-sell and advanced monitoring wins (capnography, hemodynamics, brain monitoring), (2) accelerating intelligent monitoring via AI-enabled sensors (including OIRD detection integration into next-gen sensors/monitors), and (3) innovating wearables (Radius VSM, W1, Radius PPG pilots). Management emphasized favorable contract backlog (unrecognized contract revenue of $507M expected to be recognized within 12 months, +17% YoY) and expects consumables growth to accelerate into Q4 as tougher prior-year comps normalize. The expanded strategic partnership with Philips was noted as a significant long-term opportunity to grow share within Philips’ installed base. Management will provide additional product and strategic detail at Investor Day on December 3.
Sign In
Buy MASI